Medmen Enterprises Class Stock EBITDA
Medmen Enterprises Class fundamentals help investors to digest information that contributes to Medmen Enterprises' financial success or failures. It also enables traders to predict the movement of Medmen OTC Stock. The fundamental analysis module provides a way to measure Medmen Enterprises' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medmen Enterprises otc stock.
Medmen |
Medmen Enterprises Class OTC Stock EBITDA Analysis
Medmen Enterprises' EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Current Medmen Enterprises EBITDA | (106.73 M) |
Most of Medmen Enterprises' fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medmen Enterprises Class is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
CompetitionAccording to the company disclosure, Medmen Enterprises Class reported earnings before interest,tax, depreciation and amortization of (106.73 Million). This is 112.16% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The ebitda for all United States stocks is 102.74% higher than that of the company.
Medmen EBITDA Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medmen Enterprises' direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Medmen Enterprises could also be used in its relative valuation, which is a method of valuing Medmen Enterprises by comparing valuation metrics of similar companies.Medmen Enterprises is currently under evaluation in ebitda category among its peers.
Medmen Fundamentals
| Return On Asset | -0.0522 | |||
| Profit Margin | (1.04) % | |||
| Operating Margin | (0.24) % | |||
| Current Valuation | 390.25 M | |||
| Shares Outstanding | 1.3 B | |||
| Shares Owned By Insiders | 10.98 % | |||
| Shares Owned By Institutions | 2.97 % | |||
| Price To Book | 0.25 X | |||
| Price To Sales | 0.26 X | |||
| Revenue | 140.81 M | |||
| Gross Profit | 69.73 M | |||
| EBITDA | (106.73 M) | |||
| Net Income | (195.19 M) | |||
| Cash And Equivalents | 13.53 M | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 206.38 M | |||
| Debt To Equity | 7.54 % | |||
| Current Ratio | 0.50 X | |||
| Book Value Per Share | 0.11 X | |||
| Cash Flow From Operations | (62.53 M) | |||
| Earnings Per Share | (0.14) X | |||
| Target Price | 0.32 | |||
| Number Of Employees | 428 | |||
| Beta | 1.93 | |||
| Market Capitalization | 36.33 M | |||
| Total Asset | 323.22 M | |||
| Net Asset | 323.22 M |
Currently Active Assets on Macroaxis
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in census. Note that the Medmen Enterprises Class information on this page should be used as a complementary analysis to other Medmen Enterprises' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Other Consideration for investing in Medmen OTC Stock
If you are still planning to invest in Medmen Enterprises Class check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Medmen Enterprises' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |